Barton Shane bought BIOA
September 27, 2024 · Form 4 insider transaction
Barton Shane bought 2,632 shares of BioAge Labs, Inc. at $18.00 per share, a transaction worth $47.4K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 164 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,632
Price
$18.00
Total value
$47.4K
InsiderBarton Shane
RoleOfficer
CompanyBioAge Labs, Inc. (BIOA)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateSeptember 27, 2024
Filing dateMarch 10, 2025
Shares owned after2,632
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported securities were purchased through a directed share program in connection with the Issuer's initial public offering.